Table 2. Hypothalamic-pituitary-testicular function of 8 boys with DAX-1 mutations.
Cases | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |
Testicular volume, mL | 12.8 yr:4.5 | 10 yr:213.9 yr:415.7 yr:5 | 11.6 yr: 4 | 13.6 yr:6 14.3 yr:6 | 15 yr:3.8 16.4 yr:5.4 | 15.7 yr:2 17.8 yr:3 | |||
FSH basal/peak, IU/L | 2 mo:2.6/3.9 14.8 yr:<0.4/<0.4 18.8 yr:1.3/1.7 | 6 mo:1.9/3.3 | 8 d: 1.2 | 13 d:2 13.9 yr:3/4 16.8 yr:5 19.8 yr:1 | NA | 14.3 yr:2.3/3.3 | 13.7 yr:0.9/1.616.4 yr:1.6 | 15.7 yr:1.19/1.62 | |
LH basal/peak, IU/L | 2 mo:.1/614.8 yr:<0.4/<0.418.8 yr:0.1/0.3 | 6 mo:1.2/4.5 | NA | 13 d:1.1 13.9 yr:1/1 16.8 yr:4 19.8 yr:<1 | NA | 14.3 yr:0.78/1.7 | 13.7 yr:<0.4/<0.4 16.4 yr:0.6 | 15.7 yr:0.4/0.67 | |
Testosterone, ng/mL | 2 mo:3.714.8 yr:<0.05 | 29 d:1.8 6 mo:<0.05 7.1 yr:<0.02 | 8 d: 1.1 | 13 d:1.8 10 yr:<0.04 13.9 yr:0.6 15.7 yr:3 16.8 yr:4.1 17.3 yr:0.1 | 14 d:0.1613.4 yr:0.0513.8 yr:0.16 | 13.6 yr:0.114.3 yr:0.6714.7 yr:<0.07 | 9.7 yr:<0.0515 yr:<0.0216.4 yr:0.02 | 13 yr:<0.05 14.3 yr:<0.05 15.7 yr:<0.04 | |
Inhibin B, pg/mL | 17 d:259 14.8 yr:103 | 9 mo:250 7.5 yr:19 | 8 d:225 6 mo:343 2.3 yr:27 | NA | 11.6 yr:6513.8 yr:20 | 16 yr:28 | 9.7 yr:121 13.7 yr:95 16.4 yr:94 | 29.7 yr:20 | |
AMH, pmol/L | 17 d:700 14.8 yr:103 | 9 mo:1015 7.5 yr:252 | 8 d:264 6 mo:740 2.3 yr:284 | NA | 11.6 yr:27 | NA | 9.7 yr:213 13.7 yr:237 | 20 yr:41029.7 yr:410 | |
Age at onset of testosterone, yr | 14.8 | 17.3 | 13.8 | 14.7 | 15 | 15.8 | |||
DAX mutation | ? | 2 µdel | 2 µdel | Complete deletion | µdel | µdel | Del 651 | Insertion 284 |
Normal range: Inhibin B, pg/mL, 12 mo, 94–383, 24 mo, 71–204, 5–10 yr, <20–258, adult, 80–270; AMH, pmol/L, 10d-1 yr, 390–570, 1 yr–4 yr, 360–650, 4 yr–7 yr, 320–560, 7 yr–9 yr, 240–430, adult, 22–38.
Unilateral cryptorchidism in cases 2 and 3.